The cultivated meat industry’s known struggles will take time to sort out, and maybe that’s OK


ADVERTISEMENT

The Wall Street Journal went under the hood of the lab-grown meat industry, also known as cultivated or cell-cultured meat, and the struggles within.

The Journal particularly homed in on what’s going on at UPSIDE Foods, which received a blessing from the U.S. Food and Drug Administration related to its process for making cultivated chicken, essentially saying it was safe to eat and making it the first company to receive this approval. Eat Just, which has been selling its product in Singapore, the first nation to approve the sale of cultivated meat, followed, getting its “thumbs-up” from the FDA in March.

WSJ’s story pays particular attention to UPSIDE Foods’ success at making small batches of its chicken product, as well as its lack of being able to produce large amounts of product at a low cost, or at even price parity with traditional meat — and to be fair, most cultivated meat companies struggle with this too.

“Initially our chicken will be sold at a price premium,” UPSIDE founder and CEO Uma Valeti told TechCrunch in November. “As we scale, we expect to eventually reach price parity with conventionally produced meat. Our goal is to ultimately be more affordable than conventionally produced meat.”

Companies in this sector make meat from animal cells that are fed growth factors. The production and pricing challenges presented in the WSJ story, however, are not new. “Is cell-culture meat ready for prime time?” wasn’t just a clever TechCrunch+ headline, but a legitimate question posed in early 2022 that still really hasn’t been answered.

Most cultivated meat stories in our archives include at least a sentence about how hard it is for companies to produce mass quantities and to create foods by this method so that the finished product is under $10 a pound.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Startups

Curing physician burnout with Eli Ben-Joseph form Regard

Welcome back to Found, where we get the stories behind the startups. This week Becca and Dom are joined by Eli Ben-Joseph, the co-founder and CEO of Regard, a startup that uses AI to streamline the clinical side of medicine in an effort to reduce physician burnout. Eli talked about his journey from deciding to […]

Read More
Startups

OurX adds tech spin to Black hair care regimen

Ceci Kurzman has spent much of her career building and investing in brands and serving as one of the few Black female board members for companies, including Lanvin, Revlon and Warner Music+. While investing on behalf of some clients interested in beauty and personal care, Kurzman saw a gap in what kinds of products were […]

Read More
Startups

Sensi.AI and Flint Capital speak on developing and deploying AI solutions in healthcare

Remotely monitoring patients without violating their privacy is a challenging task. But one co-founder believes that she’s cracked the code. On a recent episode of TechCrunch Live, TC’s weekly event designed to help founders build better venture-backed businesses, Romi Gubes, the CEO of Sensi.AI, spoke about how she built a company that uses audio-based AI […]

Read More
ankara escort çankaya escort çankaya escort escort bayan çankaya istanbul rus escort eryaman escort ankara escort kızılay escort istanbul escort ankara escort ankara escort escort ankara istanbul rus Escort atasehir Escort beylikduzu Escort Ankara Escort malatya Escort kuşadası Escort gaziantep Escort izmir Escort
ADVERTISEMENT